Home » Roche Wins UK NICE Backing for Tarceva in Advanced Lung Cancer
Roche Wins UK NICE Backing for Tarceva in Advanced Lung Cancer
Roche’s Tarceva lung-cancer medicine won the backing of the UK’s health-cost agency after presenting data comparing the drug with AstraZeneca’s Iressa (gefitinib), which is already recommended.
Bloomberg
Bloomberg
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May